Peptris Technologies Private

AI-driven drug discovery company using proprietary generative AI to design novel molecules and repurpose drugs for oncology, inflammation, and rare diseases.

Proprietary AI platform integrating unsupervised learning and generative AI with a novel molecule language syntax to design novel chemical entities, repurpose drugs, and rescue clinical candidates.

Competes with global AI drug discovery platforms like Exscientia, Recursion, and Insilico Medicine, but differentiates through its virtual model, focus on the Indian market, and three-pronged approach targeting novel molecules, repurposing, and clinical candidate rescue.